These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27268966)

  • 1. Applicability of two automated disintegration apparatuses for rapidly disintegrating (mini)tablets.
    Sieber D; Lazzari A; Quodbach J; Pein M
    Pharm Dev Technol; 2017 Mar; 22(2):198-205. PubMed ID: 27268966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
    Uchida T; Yoshida M; Hazekawa M; Haraguchi T; Furuno H; Teraoka M; Ikezaki H
    J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.
    Comoglu T; Dilek Ozyilmaz E
    Pharm Dev Technol; 2019 Sep; 24(7):902-914. PubMed ID: 31215850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healthy volunteers.
    Yoshita T; Uchida S; Namiki N
    Biol Pharm Bull; 2013; 36(9):1488-93. PubMed ID: 23995661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of oral disintegration time of fast disintegrating tablets using texture analyzer and computational optimization.
    Szakonyi G; Zelkó R
    Int J Pharm; 2013 May; 448(2):346-53. PubMed ID: 23558313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the palatabilities in 10 different famotidine orally disintegrating tablets by combination of disintegration device and taste sensor.
    Yoshida M; Hazekawa M; Haraguchi T; Uchida T
    Drug Dev Ind Pharm; 2015; 41(8):1387-92. PubMed ID: 25196898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
    Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution testing of orally disintegrating tablets.
    Kraemer J; Gajendran J; Guillot A; Schichtel J; Tuereli A
    J Pharm Pharmacol; 2012 Jul; 64(7):911-8. PubMed ID: 22686339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of disintegration properties of orally rapidly disintegrating tablets using a novel disintegration tester.
    Kondo K; Niwa T; Danjo K
    Chem Pharm Bull (Tokyo); 2012; 60(10):1240-8. PubMed ID: 23036967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The technologies used for developing orally disintegrating tablets: a review.
    Badgujar BP; Mundada AS
    Acta Pharm; 2011 Jun; 61(2):117-39. PubMed ID: 21684842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel and simple method to evaluate disintegration of rapidly disintegrating tablets.
    Hoashi Y; Tozuka Y; Takeuchi H
    Chem Pharm Bull (Tokyo); 2013; 61(9):962-6. PubMed ID: 23995360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution Studies of Papaverine Hydrochloride from Tablets in Three Pharmacopoeia Apparatuses.
    Polski A; Kasperek R; Rogowska M; Iwaniak K; Sobòtka-Polska K; Poleszak E
    Polim Med; 2015; 45(1):21-4. PubMed ID: 26630725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of novel multi-channel orally disintegrating tablets.
    Yu J; Shan X; Chen S; Sun X; Song P; Zhao R; Hu L
    Eur J Pharm Sci; 2020 Jan; 142():105108. PubMed ID: 31669391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of a Novel Method to Evaluate Water Permeation Rates by Combining the Dynamic Contact Angle and Thermographic Approach: Significance of Disintegration Properties of Orally Disintegrating Tablets].
    Suzuki T; Kurano T; Kanazawa T; Suzuki N
    Yakugaku Zasshi; 2020; 140(8):1071-1080. PubMed ID: 32741865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus.
    Harada T; Uchida T; Yoshida M; Kobayashi Y; Narazaki R; Ohwaki T
    Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1009-14. PubMed ID: 20686251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
    Hooper P; Lasher J; Alexander KS; Baki G
    J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally disintegrating mini-tablets (ODMTs)--a novel solid oral dosage form for paediatric use.
    Stoltenberg I; Breitkreutz J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):462-9. PubMed ID: 21324357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test.
    Harada T; Narazaki R; Nagira S; Ohwaki T; Aoki S; Iwamoto K
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1072-5. PubMed ID: 16880646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New advances in the characterization of lyophilised orally disintegrating tablets.
    Vanbillemont B; Everaert H; De Beer T
    Int J Pharm; 2020 Apr; 579():119153. PubMed ID: 32084575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of disintegration of rapidly disintegrating tablets by a visiometric liquid jet-mediated disintegration apparatus.
    Desai PM; Liew CV; Heng PW
    Int J Pharm; 2013 Feb; 442(1-2):65-73. PubMed ID: 22985772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.